Tumor response and clinical toxicity associated with second-line chemotherapy regimens for advanced non-squamous non-small cell lung cancer: A retrospective cohort study

BACKGROUND: Previously reported superior tumor response of pemetrexed in the second-line setting for advanced non-squamous non-small cell lung cancer (advNS-NSCLC) has never been confirmed in real-world studies. Platinum-based doublet is frequently used in the second-line setting for advanced NSCLC...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Thorac Cancer
Autores principales: Hu, Chengping, Wang, Yan, Chen, Jianhua, Wu, Shengqi, Li, Xiaoling, Wang, Yuqin, Yang, Yicheng, Rajan, Narayan, Papadimitropoulos, Manny, Xiao, Qiong, Zhan, Huan, Chen, Wendong
Formato: Artigo
Lenguaje:Inglês
Publicado: BlackWell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4704368/
https://ncbi.nlm.nih.gov/pubmed/26767027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12102
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares